XORTX Therapeutics Inc. Increase Decrease In Cash And Cash Equivalents
XORTX Therapeutics Inc. (XRTX) reported Increase Decrease In Cash And Cash Equivalents of CAD 18.68 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2022-05-03
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2021-12-31 | 18.68M CAD 20-F · filed 2022-05-03 |
| 2020-12-31 | 112.66K CAD 20-F · filed 2022-05-03 |
| 2019-12-31 | -201.41K CAD 20-F · filed 2022-05-03 |